Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome

Journal of Assisted Reproduction and Genetics

Volumn 17, Issue 1, 2000, Pages 13-19

  Fábregues, Francisco ^a   Balasch, Juan ^a,c   Creus, Montserrat ^a   Carmona, Francisco ^a   Puerto, Bienvenido ^a   Quintó, Llorenç ^b   Casamitjana, Roser ^a   Vanrell, Juan A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

FSH; HMG test; IVF; Low responders; Predictors of ovarian response

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INHIBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FUNCTION TEST; HUMAN; MAJOR CLINICAL STUDY; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; INHIBINS; MATERNAL AGE; MENOTROPINS; OVARY; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; REGRESSION ANALYSIS; ROC CURVE; TREATMENT OUTCOME;

EID: 0343527515     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009441812247     Document Type: Article

References (23)

1. Scott RT, Hofmann GE: Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11
2. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654
3. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791
4. Cahill DJ, Prosser CJ, Wardle PG, Ford WCL, Hull MGR: Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994;101:999-1002
5. Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA: Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 1996; 175:1226-1230
6. Farhi J, Homburg R, Ferber A, Orvieto R, Ben Rafael Z: Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: A clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997;12:241-243
7. Kim MR: Screening for ovarian reserve. Assist Reprod Rev 1998;8:17-22
8. McDonough PG, Mahesh VB, Byrd JR: The diagnostic use of gonadotropins. Fertil Steril 1970;21:126-133
9. Netter A, Millet D, Salomon-Bernard Y: Ovarian stimulation tests using human menopausal gonadotropin (HMG). J Reprod Fertil 1970;21:313-317
10. Hanley JA, McNeil BJ: The meaning and use of the area under receiving operating characteristic (ROC) curve. Radiology 1982;143:29-36
11. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577
12. Balasch J, Fábregues F, Creus M, Moreno V, Puerto B, Peñarrubia J, Carmona F, Vanrell JA: Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum Reprod 1996;11:2400-2404
13. Fábregues F, Balasch J, Creus M, Cívico S, Carmona F, Puerto B, Vanrell JA: Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertil Steril 1998;70:46-51
14. Burger HG, Groome NP, Robertson DM: Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 1998;83:4167-4169
15. Balasch J, Jové IC, Moreno V, Civico S, Puerto B, Vanrell JA: The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program. Fertil Steril 1992;58:991-994
16. de Mouzon J, Lancaster P, and the International Working Group for Registers on Assisted Reproduction: World collaborative report on in vitro fertilization. Preliminary data for 1995. J Assist Reprod Genet 1997;14:251S-265S
17. Schattman GL, Davis OK, Rosenwaks Z: Patient selection and screening for assisted reproductive technology. Infertil Reprod Med Clin North Am 1993;4:619-641
18. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather J, McNeilly AS: Measurement of dimeric inhibin B throughout the menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405
19. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA: Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;67:110-114
20. Galtier-Dereure F, De Bouard V, Picot MC, Vergnes C, Humeau C, Bringer J, Hedon B: Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: Correlation with in-vitro fertilization outcome. Hum Reprod 1996;11:1393-1398
21. Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A: The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril 1996;66:969-973
22. Franchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R: Exogenous follicle stimulating hormone ovarian reserve test (EFORT): A simple and reliable screening test for detecting "poor responders" in in-vitro fertilization. Hum Reprod 1994;9:1607-1611
23. Sharif K, Elgendy M, Lashen H, Afnan M: Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol 1998;105:107-112